SHINKEI Therapeutics logo — Speed, Quality, Life
(because patients shouldn't wait)

SHINKEI Therapeutics

Speed, Quality, Life (because patients shouldn't wait)

Founded 2017 United States Princeton, United States 4 employees Biotechnology, Health Care +1

General Information

Company Name SHINKEI Therapeutics
Founded Year 2017
Location United States Princeton, United States +1
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Social

Get notified when SHINKEI Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About SHINKEI Therapeutics

SHINKEI Therapeutics is a clinical stage CNS (Central Nervous System) disorders focused pharmaceutical company founded in 2017. Their slogan "Speed, Quality, Life (because patients shouldn't wait)" reflects their commitment to addressing patient needs efficiently. Utilizing the 505(b)2 regulatory strategy, they aim to repurpose existing pharmaceutical products for faster and better patient outcomes, with a focus on improving drug administration for previously unfeasible indications, enhancing convenience, improving compliance, and ameliorating side effects. Co-founded by industry veterans Suresh Borsadia and GP Singh, the company benefits from a blend of commercial and scientific expertise. Supported by a nimble and efficient team, SHINKEI endeavors to make a meaningful impact in the Biotechnology, Health Care, and Pharmaceutical industries. While specific details about the company’s location and recent investments are currently unavailable, SHINKEI's innovative approach and experienced leadership position it as a promising player in the pharmaceutical space.

Taxonomy: CNS disorders, Pharmaceutical development, Drug development, Neurology, Drug delivery, 505(b)(2) regulatory strategy, Clinical stage, Neurological disorders, Pharmaceutical innovation, Movement disorders, Huntington's disease, Traumatic brain injury, Pseudobulbar affect, Drug administration, Patient outcome

No funding data available for SHINKEI Therapeutics yet.

Get notified when SHINKEI Therapeutics raises funding

SHINKEI Therapeutics Alternatives & Competitors

SHINKEI Therapeutics vs

Premier clinical research site in Mississippi founded in 2004 by Dr. Joseph Kwentus.

7 employees
Health Care, Health and Wellness
SHINKEI Therapeutics vs

Innovative drug delivery solutions enhancing the development and improvement of pharmaceuticals sinc...

Series B
Biotechnology, Health Care
SHINKEI Therapeutics vs

SK Biopharmaceuticals is a global pioneer in the development of new drugs

Grant
233 employees
Biotechnology, Health and Wellness

FAQ About SHINKEI Therapeutics

Speed, Quality, Life (because patients shouldn't wait)
SHINKEI Therapeutics was founded in 2017.
SHINKEI Therapeutics is headquartered in Princeton, United States.
SHINKEI Therapeutics operates in the following industries: Biotechnology, Health Care, Pharmaceutical.
SHINKEI Therapeutics has approximately 4 employees.
Top alternatives and competitors to SHINKEI Therapeutics include Precise Research Centers, Bostal Drug Delivery, SK Biopharmaceuticals, Salient Pharmaceuticals, Emcure Pharmaceuticals USA, Inc. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
SHINKEI Therapeutics and Precise Research Centers are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors SHINKEI Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes